Prometheus Biosciences
RXDX
#1762
Rank
โ‚น806.49 B
Marketcap
โ‚น16,868
Share price
0.00%
Change (1 day)
367.37%
Change (1 year)

Revenue for Prometheus Biosciences (RXDX)

Revenue in 2023 (TTM): โ‚น0.32 Billion

According to Prometheus Biosciences's latest financial reports the company's current revenue (TTM ) is โ‚น0.33 Billion. In 2022 the company made a revenue of โ‚น0.56 Billion an increase over the revenue in the year 2021 that were of โ‚น0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prometheus Biosciences from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น0.32 B-42.54%
2022 โ‚น0.56 B141.93%
2021 โ‚น0.23 B159.11%
2020 โ‚น89.88 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น4.47 B 1,226.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.46 B 3,895.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น14.72 B 4,267.88%๐Ÿ‡บ๐Ÿ‡ธ USA